PubRank

Konstantin Chumakov

Author PubWeight™ 37.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis 2005 2.33
2 Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. J Infect Dis 2006 1.98
3 Identification of Listeria species by microarray-based assay. J Clin Microbiol 2002 1.87
4 Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 2002 1.67
5 Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J 2012 1.45
6 Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A 2003 1.33
7 Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res 2005 1.29
8 Microarray-based identification of thermophilic Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol 2003 1.21
9 Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol 2004 1.08
10 Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. J Virol Methods 2003 1.06
11 Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines. Proc Natl Acad Sci U S A 2010 1.04
12 Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol 2005 1.00
13 Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis 2007 0.98
14 Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis 2013 0.98
15 Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 2002 0.96
16 Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 2005 0.96
17 Immunisation against poliomyelitis: moving forward. Lancet 2008 0.93
18 Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s. Virology 2007 0.93
19 Quantitative one-step RT-PCR assay for rapid and sensitive identification and titration of polioviruses in clinical specimens. J Virol Methods 2013 0.92
20 Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol 2011 0.91
21 Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci U S A 2013 0.91
22 Future of polio vaccines. Expert Rev Vaccines 2009 0.91
23 Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method. Biologicals 2005 0.89
24 Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 2003 0.87
25 Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. J Med Virol 2011 0.85
26 Microarray assay for detection and discrimination of Orthopoxvirus species. J Med Virol 2006 0.85
27 Repertoire of antibodies against type 1 poliovirus in human sera. J Virol Methods 2010 0.84
28 Don't drop current vaccine until we have new ones. Nature 2005 0.80
29 Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus. J Virol Methods 2008 0.80
30 Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis 2010 0.79
31 Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene. J Med Virol 2007 0.78
32 Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV). Biologicals 2005 0.78
33 MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyes. J Virol Methods 2011 0.76
34 Environmental surveillance of viruses by tangential flow filtration and metagenomic reconstruction. Euro Surveill 2016 0.76
35 Monovalent oral poliovirus vaccines--a good tool but not a total solution. N Engl J Med 2008 0.75
36 WHO Working Group discussion on revision of the WHO recommendations for the production and control of poliomyelitis vaccines (oral): TRS Nos. 904 and 910. Report of Meeting held on 20-22 July 2010, Geneva, Switzerland. Vaccine 2011 0.75
37 Determination of poliovirus-specific IgA in saliva by ELISA tests. J Virol Methods 2005 0.75